1
|
Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa. PLoS One 2023; 18:e0281507. [PMID: 36857360 PMCID: PMC9977066 DOI: 10.1371/journal.pone.0281507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 01/24/2023] [Indexed: 03/02/2023] Open
Abstract
The 5-hydroxytrptamine 3 (5-HT3) receptor is a member of the 'Cys-loop' family and the only pentameric ligand gated ion channel among the serotonin receptors. 5-HT3 receptors play an important role in controlling growth, development, and behaviour in animals. Several 5-HT3 receptor antagonists are used to treat diseases (e.g., irritable bowel syndrome, nausea and emesis). Humans express five different subunits (A-E) enabling a variety of heteromeric receptors to form but all contain 5HT3A subunits. However, the information available about the 5-HT3 receptor subunit occurrence among the metazoan lineages is minimal. In the present article we searched for 5-HT3 receptor subunit homologs from different phyla in Metazoa. We identified more than 1000 5-HT3 receptor subunits in Metazoa in different phyla and undertook simultaneous phylogenetic analysis of 526 5HT3A, 358 5HT3B, 239 5HT3C, 70 5HT3D, and 173 5HT3E sequences. 5-HT3 receptor subunits were present in species belonging to 11 phyla: Annelida, Arthropoda, Chordata, Cnidaria, Echinodermata, Mollusca, Nematoda, Orthonectida, Platyhelminthes, Rotifera and Tardigrada. All subunits were most often identified in Chordata phylum which was strongly represented in searches. Using multiple sequence alignment, we investigated variations in the ligand binding region of the 5HT3A subunit protein sequences in the metazoan lineage. Several critical amino acid residues important for ligand binding (common structural features) are commonly present in species from Nematoda and Platyhelminth gut parasites through to Chordata. Collectively, this better understanding of the 5-HT3 receptor evolutionary patterns raises possibilities of future pharmacological challenges facing Metazoa including effects on parasitic and other species in ecosystems that contain 5-HT3 receptor ligands.
Collapse
|
2
|
Eom S, Jung W, Lee J, Yeom HD, Lee S, Kim C, Park HD, Lee JH. Differential Regulation of Human Serotonin Receptor Type 3A by Chanoclavine and Ergonovine. Molecules 2021; 26:molecules26051211. [PMID: 33668306 PMCID: PMC7956620 DOI: 10.3390/molecules26051211] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 02/07/2023] Open
Abstract
Irritable bowel syndrome (IBS) is a chronic disease that causes abdominal pain and an imbalance of defecation patterns due to gastrointestinal dysfunction. The cause of IBS remains unclear, but intestinal-brain axis problems and neurotransmitters have been suggested as factors. In this study, chanoclavine, which has a ring structure similar to 5-hydroxytryptamine (5-HT), showed an interaction with the 5-HT3A receptor to regulate IBS. Although its derivatives are known to be involved in neurotransmitter receptors, the molecular physiological mechanism of the interaction between chanoclavine and the 5-HT3A receptor is unknown. Electrophysiological experiments were conducted using a two-electrode voltage-clamp analysis to observe the inhibitory effects of chanoclavine on Xenopus oocytes in which the h5-HT3A receptor was expressed. The co-application of chanoclavine and 5-HT resulted in concentration-dependent, reversible, voltage-independent, and competitive inhibition. The 5-HT3A response induced by 5-HT was blocked by chanoclavine with half-maximal inhibitory response concentration (IC50) values of 107.2 µM. Docking studies suggested that chanoclavine was positioned close F130 and N138 in the 5-HT3A receptor-binding site. The double mutation of F130A and N138A significantly attenuated the interaction of chanoclavine compared to a single mutation or the wild type. These data suggest that F130 and N138 are important sites for ligand binding and activity. Chanoclavine and ergonovine have different effects. Asparagine, the 130th amino acid sequence of the 5-HT3A receptor, and phenylalanine, the 138th, are important in the role of binding chanoclavine, but ergonovine has no interaction with any amino acid sequence of the 5-HT3A receptor. The results of the electrophysiological studies and of in silico simulation showed that chanoclavine has the potential to inhibit the hypergastric stimulation of the gut by inhibiting the stimulation of signal transduction through 5-HT3A receptor stimulation. These findings suggest chanoclavine as a potential antiemetic agent for excessive gut stimulation and offer insight into the mechanisms of 5-HT3A receptor inhibition.
Collapse
Affiliation(s)
- Sanung Eom
- Department of Biotechnology, Chonnam National University, Gwangju 61186, Korea; (S.E.); (J.L.); (S.L.); (C.K.)
| | - Woog Jung
- School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea;
| | - Jaeeun Lee
- Department of Biotechnology, Chonnam National University, Gwangju 61186, Korea; (S.E.); (J.L.); (S.L.); (C.K.)
| | | | - Shinhui Lee
- Department of Biotechnology, Chonnam National University, Gwangju 61186, Korea; (S.E.); (J.L.); (S.L.); (C.K.)
| | - Chaelin Kim
- Department of Biotechnology, Chonnam National University, Gwangju 61186, Korea; (S.E.); (J.L.); (S.L.); (C.K.)
| | - Heui-Dong Park
- School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea;
- Correspondence: (H.-D.P.); (J.H.L); Tel.: +82-53-950-5774 (H.-D.P.); +82-62-530-2164 (J.H.L.)
| | - Junho H. Lee
- Department of Biotechnology, Chonnam National University, Gwangju 61186, Korea; (S.E.); (J.L.); (S.L.); (C.K.)
- Correspondence: (H.-D.P.); (J.H.L); Tel.: +82-53-950-5774 (H.-D.P.); +82-62-530-2164 (J.H.L.)
| |
Collapse
|
3
|
Gibbs E, Chakrapani S. Structure, Function and Physiology of 5-Hydroxytryptamine Receptors Subtype 3. Subcell Biochem 2021; 96:373-408. [PMID: 33252737 DOI: 10.1007/978-3-030-58971-4_11] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
5-hydroxytryptamine receptor subtype 3 (5-HT3R) is a pentameric ligand-gated ion channel (pLGIC) involved in neuronal signaling. It is best known for its prominent role in gut-CNS signaling though there is growing interest in its other functions, particularly in modulating non-serotonergic synaptic activity. Recent advances in structural biology have provided mechanistic understanding of 5-HT3R function and present new opportunities for the field. This chapter gives a broad overview of 5-HT3R from a physiological and structural perspective and then discusses the specific details of ion permeation, ligand binding and allosteric coupling between these two events. Biochemical evidence is summarized and placed within a physiological context. This perspective underscores the progress that has been made as well as outstanding challenges and opportunities for future 5-HT3R research.
Collapse
Affiliation(s)
- Eric Gibbs
- Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, 44106-4970, USA.
| | - Sudha Chakrapani
- Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, 44106-4970, USA. .,Department of Neuroscience, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106-4970, USA.
| |
Collapse
|
4
|
Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases. Processes (Basel) 2019. [DOI: 10.3390/pr7120940] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
In recent years, green chemistry has been strengthening, showing how basic and applied sciences advance globally, protecting the environment and human health. A clear example of this evolution is the synergy that now exists between theoretical and computational methods to design new drugs in the most efficient possible way, using the minimum of reagents and obtaining the maximum yield. The development of compounds with potential therapeutic activity against multiple targets associated with neurodegenerative diseases/disorders (NDD) such as Alzheimer’s disease is a hot topic in medical chemistry, where different scientists from various disciplines collaborate to find safe, active, and effective drugs. NDD are a public health problem, affecting mainly the population over 60 years old. To generate significant progress in the pharmacological treatment of NDD, it is necessary to employ different experimental strategies of green chemistry, medical chemistry, and molecular biology, coupled with computational and theoretical approaches such as molecular simulations and chemoinformatics, all framed in the rational drug design targeting NDD. Here, we review how green chemistry and computational approaches have been used to develop new compounds with the potential application against NDD, as well as the challenges and new directions of the drug development multidisciplinary process.
Collapse
|
5
|
Wong-Lin K, Wang DH, Moustafa AA, Cohen JY, Nakamura K. Toward a multiscale modeling framework for understanding serotonergic function. J Psychopharmacol 2017; 31:1121-1136. [PMID: 28417684 PMCID: PMC5606304 DOI: 10.1177/0269881117699612] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Despite its importance in regulating emotion and mental wellbeing, the complex structure and function of the serotonergic system present formidable challenges toward understanding its mechanisms. In this paper, we review studies investigating the interactions between serotonergic and related brain systems and their behavior at multiple scales, with a focus on biologically-based computational modeling. We first discuss serotonergic intracellular signaling and neuronal excitability, followed by neuronal circuit and systems levels. At each level of organization, we will discuss the experimental work accompanied by related computational modeling work. We then suggest that a multiscale modeling approach that integrates the various levels of neurobiological organization could potentially transform the way we understand the complex functions associated with serotonin.
Collapse
Affiliation(s)
- KongFatt Wong-Lin
- Intelligent Systems Research Centre, School of Computing and Intelligent Systems, University of Ulster, Magee Campus, Derry~Londonderry, UK
| | - Da-Hui Wang
- School of Systems Science, and National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China
| | - Ahmed A Moustafa
- School of Social Sciences and Psychology, and Marcs Institute for Brain and Behaviour, University of Western Sydney, Sydney, Australia
| | - Jeremiah Y Cohen
- Solomon H. Snyder Department of Neuroscience, Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, USA
| | - Kae Nakamura
- Department of Physiology, Kansai Medical University, Hirakata, Osaka, Japan
| |
Collapse
|
6
|
Alix K, Khatri S, Mosier PD, Casterlow S, Yan D, Nyce HL, White MM, Schulte MK, Dukat M. Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT 3) Subunit A Receptors. ACS Chem Neurosci 2016; 7:1565-1574. [PMID: 27533595 DOI: 10.1021/acschemneuro.6b00196] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Introduction of minor variations to the substitution pattern of arylguanidine 5-hydroxytryptamine-3 (5-HT3) receptor ligands resulted in a broad spectrum of functionally-active ligands from antagonist to superagonist. For example, (i) introduction of an additional Cl-substituent(s) to our lead full agonist N-(3-chlorophenyl)guanidine (mCPG, 2; efficacy % = 106) yielded superagonists 7-9 (efficacy % = 186, 139, and 129, respectively), (ii) a positional isomer of 2, p-Cl analog 11, displayed partial agonist actions (efficacy % = 12), and (iii) replacing the halogen atom at the meta or para position with an electron donating OCH3 group or a stronger electron withdrawing (i.e., CF3) group resulted in antagonists 13-16. We posit based on combined mutagenesis, crystallographic, and computational analyses that for the 5-HT3 receptor, the arylguanidines that are better able to simultaneously engage the primary and complementary subunits, thus keeping them in close proximity, have greater agonist character while those that are deficient in this ability are antagonists.
Collapse
Affiliation(s)
- Katie Alix
- Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States
| | - Shailesh Khatri
- Department
of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of Sciences, Philadelphia, Pennsylvania 19104, United States
| | - Philip D. Mosier
- Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States
| | - Samantha Casterlow
- Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States
| | - Dong Yan
- Department
of Biochemistry and Molecular Biology Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| | - Heather L. Nyce
- Department
of Biochemistry and Molecular Biology Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| | - Michael M. White
- Department
of Biochemistry and Molecular Biology Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| | - Marvin K. Schulte
- Department
of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of Sciences, Philadelphia, Pennsylvania 19104, United States
| | - Małgorzata Dukat
- Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States
| |
Collapse
|
7
|
Lohning AE, Marx W, Isenring L. In silico investigation into the interactions between murine 5-HT 3 receptor and the principle active compounds of ginger (Zingiber officinale). J Mol Graph Model 2016; 70:315-327. [PMID: 27816008 DOI: 10.1016/j.jmgm.2016.10.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2016] [Revised: 10/06/2016] [Accepted: 10/07/2016] [Indexed: 11/18/2022]
Abstract
Gingerols and shogaols are the primary non-volatile actives within ginger (Zingiber officinale). These compounds have demonstrated in vitro to exert 5-HT3 receptor antagonism which could benefit chemotherapy-induced nausea and vomiting (CINV). The site and mechanism of action by which these compounds interact with the 5-HT3 receptor is not fully understood although research indicates they may bind to a currently unidentified allosteric binding site. Using in silico techniques, such as molecular docking and GRID analysis, we have characterized the recently available murine 5-HT3 receptor by identifying sites of strong interaction with particular functional groups at both the orthogonal (serotonin) site and a proposed allosteric binding site situated at the interface between the transmembrane region and the extracellular domain. These were assessed concurrently with the top-scoring poses of the docked ligands and included key active gingerols, shogaols and dehydroshogaols as well as competitive antagonists (e.g. setron class of pharmacologically active drugs), serotonin and its structural analogues, curcumin and capsaicin, non-competitive antagonists and decoys. Unexpectedly, we found that the ginger compounds and their structural analogs generally outscored other ligands at both sites. Our results correlated well with previous site-directed mutagenesis studies in identifying key binding site residues. We have identified new residues important for binding the ginger compounds. Overall, the results suggest that the ginger compounds and their structural analogues possess a high binding affinity to both sites. Notwithstanding the limitations of such theoretical analyses, these results suggest that the ginger compounds could act both competitively or non-competitively as has been shown for palonosetron and other modulators of CYS loop receptors.
Collapse
Affiliation(s)
- Anna E Lohning
- Faculty of Health Sciences & Medicine, Bond University, Gold Coast, 4229, Australia.
| | - Wolfgang Marx
- Faculty of Health Sciences & Medicine, Bond University, Gold Coast, 4229, Australia.
| | - Liz Isenring
- Faculty of Health Sciences & Medicine, Bond University, Gold Coast, 4229, Australia.
| |
Collapse
|
8
|
Di Maio D, Chandramouli B, Brancato G. Pathways and Barriers for Ion Translocation through the 5-HT3A Receptor Channel. PLoS One 2015; 10:e0140258. [PMID: 26465896 PMCID: PMC4605793 DOI: 10.1371/journal.pone.0140258] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Accepted: 09/12/2015] [Indexed: 11/29/2022] Open
Abstract
Pentameric ligand gated ion channels (pLGICs) are ionotropic receptors that mediate fast intercellular communications at synaptic level and include either cation selective (e.g., nAChR and 5-HT3) or anion selective (e.g., GlyR, GABAA and GluCl) membrane channels. Among others, 5-HT3 is one of the most studied members, since its first cloning back in 1991, and a large number of studies have successfully pinpointed protein residues critical for its activation and channel gating. In addition, 5-HT3 is also the target of a few pharmacological treatments due to the demonstrated benefits of its modulation in clinical trials. Nonetheless, a detailed molecular analysis of important protein features, such as the origin of its ion selectivity and the rather low conductance as compared to other channel homologues, has been unfeasible until the recent crystallization of the mouse 5-HT3A receptor. Here, we present extended molecular dynamics simulations and free energy calculations of the whole 5-HT3A protein with the aim of better understanding its ion transport properties, such as the pathways for ion permeation into the receptor body and the complex nature of the selectivity filter. Our investigation unravels previously unpredicted structural features of the 5-HT3A receptor, such as the existence of alternative intersubunit pathways for ion translocation at the interface between the extracellular and the transmembrane domains, in addition to the one along the channel main axis. Moreover, our study offers a molecular interpretation of the role played by an arginine triplet located in the intracellular domain on determining the characteristic low conductance of the 5-HT3A receptor, as evidenced in previous experiments. In view of these results, possible implications on other members of the superfamily are suggested.
Collapse
Affiliation(s)
- Danilo Di Maio
- Scuola Normale Superiore, Piazza dei Cavalieri 7, I-56126, Pisa, Italy
| | | | - Giuseppe Brancato
- Scuola Normale Superiore, Piazza dei Cavalieri 7, I-56126, Pisa, Italy
- * E-mail:
| |
Collapse
|
9
|
Zhou ZL, Liu HL, Wu JW, Tsao CW, Chen WH, Liu KT, Ho Y. Combining Structure-Based Pharmacophore andIn SilicoApproaches to Discover Novel Selective Serotonin Reuptake Inhibitors. Chem Biol Drug Des 2013; 82:705-17. [DOI: 10.1111/cbdd.12192] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2013] [Revised: 06/20/2013] [Accepted: 07/09/2013] [Indexed: 01/04/2023]
Affiliation(s)
- Zheng-Li Zhou
- Institute of Biochemical and Biomedical Engineering; National Taipei University of Technology; 1 Sec. 3 ZhongXiao E. Road Taipei 10608 Taiwan
| | - Hsuan-Liang Liu
- Institute of Biochemical and Biomedical Engineering; National Taipei University of Technology; 1 Sec. 3 ZhongXiao E. Road Taipei 10608 Taiwan
- Department of Chemical Engineering and Biotechnology; National Taipei University of Technology; 1 Sec. 3 ZhongXiao E. Road Taipei 10608 Taiwan
| | - Josephine W. Wu
- Department of Optometry; Central Taiwan University of Science and Technology; 666 Buzih Road Taichung 40601 Taiwan
| | - Cheng-Wen Tsao
- Department of Applied Cosmetology; Taoyuan Innovation Institute of Technology; 414 Sec. 3, Jhongshan E. Road Jhongli City Taoyuan County 32091 Taiwan
| | - Wei-Hsi Chen
- Chemistry Division; Institute of Nuclear Energy Research; 1000 Wunhua Road Longtan Township Taoyuan County 32546 Taiwan
| | - Kung-Tien Liu
- Everlight Chemical Industrial Corporation; 6th Fl, 77, Tun Hua South Road, Sec.2 Taipei 106 Taiwan
| | - Yih Ho
- School of Pharmacy; Taipei Medical University; 250 Wu-Hsing Street Taipei 110 Taiwan
| |
Collapse
|
10
|
Bharadwaj VS, Dean AM, Maupin CM. Insights into the Glycyl Radical Enzyme Active Site of Benzylsuccinate Synthase: A Computational Study. J Am Chem Soc 2013; 135:12279-88. [DOI: 10.1021/ja404842r] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Vivek S. Bharadwaj
- Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden,
Colorado 80401, United States
| | - Anthony M. Dean
- Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden,
Colorado 80401, United States
| | - C. Mark Maupin
- Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden,
Colorado 80401, United States
| |
Collapse
|
11
|
Silva-Lopez EI, Barden AO, Brozik JA. Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors. Bioorg Med Chem Lett 2013; 23:773-5. [DOI: 10.1016/j.bmcl.2012.11.082] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2012] [Revised: 11/12/2012] [Accepted: 11/20/2012] [Indexed: 10/27/2022]
|
12
|
Na JH, Shin J, Jung Y, Lim D, Shin YK, Yu YG. Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes. Protein Expr Purif 2013; 88:190-5. [PMID: 23321066 DOI: 10.1016/j.pep.2013.01.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2012] [Revised: 12/31/2012] [Accepted: 01/02/2013] [Indexed: 10/27/2022]
Abstract
Human serotonin receptor 3A (5-HT3A) is a ligand-gated ion channel regulated by serotonin. A fusion protein (P9-5-HT3A) of 5-HT3A with the P9 protein, a major envelope protein of bacteriophage phi6, was highly expressed in the membrane fraction of Escherichia coli, and the expressed protein was purified to homogeneity using an affinity chromatography. P9-5-HT3A was observed as mixed oligomers in detergents. The purified P9-5-HT3A was efficiently reconstituted into proteoliposomes, and the serotonin-dependent ion-channel activity of P9-5-HT3A was observed by measuring the increased fluorescence of Fluo-3 attributed to the formation of a complex with the Ca(2+) ions released from the proteoliposomes. Alanine substitution for Trp178 of 5-HT3A abolished the serotonin-dependent ion-channel activity, confirming the importance of Trp178 as a ligand-binding site. Furthermore, the ion-channel activity of the reconstituted P9-5-HT3A was effectively blocked by treatment with ondansetron, an antagonist of 5-HT3A. The bacterial expression system of human 5-HT3A and the proteoliposomes reconstituted with 5-HT3A would provide biophysical and structural analyses of 5-HT3A.
Collapse
Affiliation(s)
- Jung-Hyun Na
- Department of Chemistry, Kookmin University, Seoul 136-702, Republic of Korea
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
5-Hydroxytryptamine type 3 (5-HT(3)) receptors are cation-selective Cys loop receptors found in both the central and peripheral nervous systems. There are five 5-HT(3) receptor subunits (A-E), and all functional receptors require at least one A subunit. Regions from noncontiguous parts of the subunit sequence contribute to the agonist-binding site, and the roles of a range of amino acid residues that form the binding pocket have been identified. Drugs that selectively antagonize 5-HT(3) receptors (the "setrons") are the current gold standard for treatment of chemotherapy-induced and postoperative nausea and vomiting and have potential for the treatment of a range of other conditions.
Collapse
Affiliation(s)
- Sarah C R Lummis
- Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, UK.
| |
Collapse
|
14
|
De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT3receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn 2012; 30:280-98. [DOI: 10.1080/07391102.2012.680029] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
15
|
Hernando G, Bergé I, Rayes D, Bouzat C. Contribution of Subunits to Caenorhabditis elegans Levamisole-Sensitive Nicotinic Receptor Function. Mol Pharmacol 2012; 82:550-60. [DOI: 10.1124/mol.112.079962] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
16
|
Buchapudi K, Xu X, Ataian Y, Ji HF, Schulte M. Micromechanical measurement of AChBP binding for label-free drug discovery. Analyst 2012; 137:263-8. [DOI: 10.1039/c1an15734e] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
17
|
Bouzat C. New insights into the structural bases of activation of Cys-loop receptors. ACTA ACUST UNITED AC 2011; 106:23-33. [PMID: 21995938 DOI: 10.1016/j.jphysparis.2011.09.012] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2011] [Revised: 09/07/2011] [Accepted: 09/26/2011] [Indexed: 11/27/2022]
Abstract
Neurotransmitter receptors of the Cys-loop superfamily mediate rapid synaptic transmission throughout the nervous system, and include receptors activated by ACh, GABA, glycine and serotonin. They are involved in physiological processes, including learning and memory, and in neurological disorders, and they are targets for clinically relevant drugs. Cys-loop receptors assemble either from five copies of one type of subunit, giving rise to homomeric receptors, or from several types of subunits, giving rise to heteromeric receptors. Homomeric receptors are invaluable models for probing fundamental relationships between structure and function. Receptors contain a large extracellular domain that carries the binding sites and a transmembrane region that forms the ion pore. How the structural changes elicited by agonist binding are propagated through a distance of 50Å to the ion channel gate is central to understanding receptor function. Depending on the receptor subtype, occupancy of either two, as in the prototype muscle nicotinic receptor, or three binding sites, as in homomeric receptors, is required for full activation. The conformational changes initiated at the binding sites are propagated to the gate through the interface between the extracellular and transmembrane domains. This region forms a network that relays structural changes from the binding site towards the pore, and also contributes to open channel lifetime and rate of desensitization. Thus, this coupling region controls the beginning and duration of a synaptic response. Here we review recent advances in the molecular mechanism by which Cys-loop receptors are activated with particular emphasis on homomeric receptors.
Collapse
Affiliation(s)
- Cecilia Bouzat
- Instituto de Investigaciones Bioquímicas, Universidad Nacional del Sur and CONICET, 8000 Bahía Blanca, Argentina.
| |
Collapse
|
18
|
Akdemir A, Rucktooa P, Jongejan A, Elk RV, Bertrand S, Sixma TK, Bertrand D, Smit AB, Leurs R, de Graaf C, de Esch IJ. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors. Bioorg Med Chem 2011; 19:6107-19. [DOI: 10.1016/j.bmc.2011.08.028] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2011] [Revised: 08/10/2011] [Accepted: 08/12/2011] [Indexed: 12/22/2022]
|
19
|
Thompson AJ, Price KL, Lummis SCR. Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors. J Physiol 2011; 589:4243-57. [PMID: 21708905 PMCID: PMC3180581 DOI: 10.1113/jphysiol.2011.208439] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
The ligand binding site of Cys-loop receptors is formed by residues on the principal (+) and complementary (-) faces of adjacent subunits, but the subunits that constitute the binding pocket in many heteromeric receptors are not yet clear. To probe the subunits involved in ligand binding in heteromeric human 5-HT(3)AB receptors, we made cysteine substitutions to the + and - faces of A and B subunits, and measured their functional consequences in receptors expressed in Xenopus oocytes. All A subunit mutations altered or eliminated function. The same pattern of changes was seen at homomeric and heteromeric receptors containing cysteine substitutions at A(R92) (- face), A(L126)(+), A(N128)(+), A(I139)(-), A(Q151)(-) and A(T181)(+), and these receptors displayed further changes when the sulphydryl modifying reagent methanethiosulfonate-ethylammonium (MTSEA) was applied. Modifications of A(R92C)(-)- and A(T181C)(+)-containing receptors were protected by the presence of agonist (5-HT) or antagonist (d-tubocurarine). In contrast modifications of the equivalent B subunit residues did not alter heteromeric receptor function. In addition a double mutant, A(S206C)(-)(/E229C)(+), only responded to 5-HT following DTT treatment in both homomeric and heteromeric receptors, indicating receptor function was inhibited by a disulphide bond between an A+ and an A- interface in both receptor types. Our results are consistent with binding to an A+A- interface at both homomeric and heteromeric human 5-HT(3) receptors, and explain why the competitive pharmacologies of these two receptors are identical.
Collapse
Affiliation(s)
- A J Thompson
- Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, UK
| | | | | |
Collapse
|
20
|
Pless SA, Hanek AP, Price KL, Lynch JW, Lester HA, Dougherty DA, Lummis SCR. A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists. Mol Pharmacol 2011; 79:742-8. [PMID: 21266487 DOI: 10.1124/mol.110.069583] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Cation-π interactions have been demonstrated to play a major role in agonist-binding in Cys-loop receptors. However, neither the aromatic amino acid contributing to this interaction nor its location is conserved among Cys-loop receptors. Likewise, it is not clear how many different agonists of a given receptor form a cation-π interaction or, if they do, whether it is with the same aromatic amino acid as the major physiological agonist. We demonstrated previously that Phe159 in the glycine receptor (GlyR) α1 subunit forms a strong cation-π interaction with the principal agonist, glycine. In the current study, we investigated whether the lower efficacy agonists of the human GlyR β-alanine and taurine also form cation-π interactions with Phe159. By incorporating a series of unnatural amino acids, we found cation-π interactions between Phe159 and the amino groups of β-alanine and taurine. The strengths of these interactions were significantly weaker than for glycine. Modeling studies suggest that β-alanine and taurine are orientated subtly differently in the binding pocket, with their amino groups further from Phe159 than that of glycine. These data therefore show that similar agonists can have similar but not identical orientations and interactions in the binding pocket and provide a possible explanation for the lower potencies of β-alanine and taurine.
Collapse
Affiliation(s)
- Stephan A Pless
- School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia
| | | | | | | | | | | | | |
Collapse
|
21
|
Poudel KR, Keller DJ, Brozik JA. Single particle tracking reveals corralling of a transmembrane protein in a double-cushioned lipid bilayer assembly. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2011; 27:320-327. [PMID: 21141848 DOI: 10.1021/la104133m] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
A predominate question associated with supported bilayer assemblies containing proteins is whether or not the proteins remain active after incorporation. The major cause for concern is that strong interactions with solid supports can render the protein inactive. To address this question, a large transmembrane protein, the serotonin receptor, 5HT(3A), has been incorporated into several supported membrane bilayer assemblies of increasing complexity. The 5HT(3A) receptor has large extracellular domains on both sides of the membrane, which could cause strong interactions. The bilayer assemblies include a simple POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) supported planar bilayer, a “single-cushion” POPC bilayer with a PEG (poly(ethylene glycol)) layer between membrane and support, and a “double-cushion” POPC bilayer with both a PEG layer and a layer of BSA (bovine serum albumin). Single-cushion systems are designed to lift the bilayer from the surface, and double-cushion systems are designed to both lift the membrane and passivate the solid support. As in previously reported work, protein mobilities measured by ensemble fluorescence recovery after photobleaching (FRAP) are quite low, especially in the double-cushion system. But single-particle tracking of fluorescent 5HT(3A) molecules shows that individual proteins in the double-cushion system have quite high local mobilities but are spatially confined within small corralling domains (<r(C)2> 450 nm). Comparisons with the simple POPC membrane and the single-cushion POPC−PEG membrane reveal that BSA both serves to minimize interactions with the solid support and creates the corrals that reduce the long-range (ensemble averaged) mobility of large transmembrane proteins. These results suggest that in double-cushion assemblies proteins with large extra-membrane domains may remain active and unperturbed despite low bulk diffusion constants.
Collapse
Affiliation(s)
- Kumud R Poudel
- Department of Chemistry, Washington State University, PO Box 644630, Pullman, Washington 99164-4630, United States
| | | | | |
Collapse
|
22
|
Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors. Eur J Med Chem 2010; 45:4746-60. [DOI: 10.1016/j.ejmech.2010.07.039] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2010] [Revised: 06/18/2010] [Accepted: 07/20/2010] [Indexed: 11/25/2022]
|
23
|
Abstract
Cys-loop receptors are membrane-spanning neurotransmitter-gated ion channels that are responsible for fast excitatory and inhibitory transmission in the peripheral and central nervous systems. The best studied members of the Cys-loop family are nACh, 5-HT3, GABAA and glycine receptors. All these receptors share a common structure of five subunits, pseudo-symmetrically arranged to form a rosette with a central ion-conducting pore. Some are cation selective (e.g. nACh and 5-HT3) and some are anion selective (e.g. GABAA and glycine). Each receptor has an extracellular domain (ECD) that contains the ligand-binding sites, a transmembrane domain (TMD) that allows ions to pass across the membrane, and an intracellular domain (ICD) that plays a role in channel conductance and receptor modulation. Cys-loop receptors are the targets for many currently used clinically relevant drugs (e.g. benzodiazepines and anaesthetics). Understanding the molecular mechanisms of these receptors could therefore provide the catalyst for further development in this field, as well as promoting the development of experimental techniques for other areas of neuroscience.In this review, we present our current understanding of Cys-loop receptor structure and function. The ECD has been extensively studied. Research in this area has been stimulated in recent years by the publication of high-resolution structures of nACh receptors and related proteins, which have permitted the creation of many Cys loop receptor homology models of this region. Here, using the 5-HT3 receptor as a typical member of the family, we describe how homology modelling and ligand docking can provide useful but not definitive information about ligand interactions. We briefly consider some of the many Cys-loop receptors modulators. We discuss the current understanding of the structure of the TMD, and how this links to the ECD to allow channel gating, and consider the roles of the ICD, whose structure is poorly understood. We also describe some of the current methods that are beginning to reveal the differences between different receptor states, and may ultimately show structural details of transitions between them.
Collapse
|
24
|
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor. Biophys J 2010; 98:1494-502. [PMID: 20409468 DOI: 10.1016/j.bpj.2009.12.4313] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Revised: 10/22/2009] [Accepted: 12/02/2009] [Indexed: 11/24/2022] Open
Abstract
The 5-HT3 receptor is a member of the Cys-loop family of transmitter receptors. It can function as a homopentamer (5-HT3A-only subunits) or as a heteropentamer. The 5-HT3AB receptor is the best characterized heteropentamer. This receptor differs from a homopentamer in its kinetics, voltage dependence, and single-channel conductance, but its pharmacology is similar. To understand the contribution of the 5-HT3B subunit to the binding site, we created homology models of 5-HT3AB receptors and docked 5-HT and granisetron into AB, BA, and BB interfaces. To test whether ligands bind in any or all of these interfaces, we mutated amino acids that are important for agonist and antagonist binding in the 5-HT3A subunit to their corresponding residues in the 5-HT3B subunit and vice versa. Changes in [3H]granisetron binding affinity (Kd) and 5-HT EC50 were determined using receptors expressed in HEK-293 cells and Xenopus oocytes, respectively. For all A-to-B mutant receptors, except T181N, antagonist binding was altered or eliminated. Functional studies revealed that either the receptors were nonfunctional or the EC50 values were increased. In B-to-A mutant receptors there were no changes in Kd, although EC50 values and Hill slopes, except for N170T mutant receptors, were similar to those for 5-HT3A receptors. Thus, the experimental data do not support a contribution of the 5-HT3B subunit to the binding pocket, and we conclude that both 5-HT and granisetron bind to an AA binding site in the heteromeric 5-HT3AB receptor.
Collapse
|
25
|
Vernekar SKV, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SCR, Lochner M. Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives. J Med Chem 2010; 53:2324-8. [PMID: 20146481 PMCID: PMC4166935 DOI: 10.1021/jm901827x] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
![]()
This report describes the synthesis and biological characterization of novel granisetron derivatives that are antagonists of the human serotonin (5-HT3A) receptor. Some of these substituted granisetron derivatives showed low nanomolar binding affinity and allowed the identification of positions on the granisetron core that might be used as attachment points for biophysical tags. A BODIPY fluorophore was appended to one such position and specifically bound to 5-HT3A receptors in mammalian cells.
Collapse
|
26
|
Bartos M, Corradi J, Bouzat C. Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region. Mol Neurobiol 2009; 40:236-52. [PMID: 19859835 DOI: 10.1007/s12035-009-8084-x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2009] [Accepted: 09/22/2009] [Indexed: 10/25/2022]
Abstract
Cys-loop receptors mediate rapid transmission throughout the nervous system by converting a chemical signal into an electric one. They are pentameric proteins with an extracellular domain that carries the transmitter binding sites and a transmembrane region that forms the ion pore. Their essential function is to couple the binding of the agonist at the extracellular domain to the opening of the ion pore. How the structural changes elicited by agonist binding are propagated through a distance of 50 A to the gate is therefore central for the understanding of the receptor function. A step forward toward the identification of the structures involved in gating has been given by the recently elucidated high-resolution structures of Cys-loop receptors and related proteins. The extracellular-transmembrane interface has attracted attention because it is a structural transition zone where beta-sheets from the extracellular domain merge with alpha-helices from the transmembrane domain. Within this zone, several regions form a network that relays structural changes from the binding site toward the pore, and therefore, this interface controls the beginning and duration of a synaptic response. In this review, the most recent findings on residues and pairwise interactions underlying channel gating are discussed, the main focus being on the extracellular-transmembrane interface.
Collapse
Affiliation(s)
- Mariana Bartos
- Instituto de Investigaciones Bioquímicas, UNS-CONICET, Bahía Blanca, Argentina
| | | | | |
Collapse
|
27
|
Rucktooa P, Smit AB, Sixma TK. Insight in nAChR subtype selectivity from AChBP crystal structures. Biochem Pharmacol 2009; 78:777-87. [DOI: 10.1016/j.bcp.2009.06.098] [Citation(s) in RCA: 96] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2009] [Revised: 06/19/2009] [Accepted: 06/22/2009] [Indexed: 10/20/2022]
|
28
|
Melis C, Bussi G, Lummis SCR, Molteni C. Trans-cis switching mechanisms in proline analogues and their relevance for the gating of the 5-HT3 receptor. J Phys Chem B 2009; 113:12148-53. [PMID: 19663504 PMCID: PMC2733763 DOI: 10.1021/jp9046962] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2009] [Indexed: 12/17/2022]
Abstract
Trans-cis isomerization of a proline peptide bond is a potential mechanism to open the channel of the 5-HT(3) receptor. Here, we have used the metadynamics method to theoretically explore such a mechanism. We have determined the free energy surfaces in aqueous solution of a series of dipeptides of proline analogues and evaluated the free energy difference between the cis and trans isomers. These theoretical results were then compared with data from mutagenesis experiments, in which the response of the 5-HT(3) receptor was measured when the proline at the apex of the M2-M3 transmembrane domain loop was mutated. The strong correlation between the experimental and the theoretical data supports the existence of a trans-cis proline switch for opening the 5-HT(3) receptor ion channel.
Collapse
Affiliation(s)
| | | | | | - Carla Molteni
- Corresponding author. Phone: +44 20 78482170. Fax: +44 20 7848 2420. E-mail:
| |
Collapse
|
29
|
Hazai E, Joshi P, Skoviak EC, Suryanarayanan A, Schulte MK, Bikadi Z. A comprehensive study on the 5-hydroxytryptamine3A receptor binding of agonists serotonin and m-chlorophenylbiguanidine. Bioorg Med Chem 2009; 17:5796-805. [DOI: 10.1016/j.bmc.2009.07.022] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2009] [Revised: 07/06/2009] [Accepted: 07/13/2009] [Indexed: 01/07/2023]
|
30
|
Paulsen IM, Martin IL, Dunn SMJ. Isomerization of the proline in the M2-M3 linker is not required for activation of the human 5-HT3A receptor. J Neurochem 2009; 110:870-8. [PMID: 19457066 DOI: 10.1111/j.1471-4159.2009.06180.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Each subunit of the cation-selective members of the Cys-loop family of ligand-gated ion channels contains a conserved proline residue in the extracellular loop between the second and third transmembrane domains. In the mouse homomeric 5-hydroxytryptamine type 3A (5-HT(3)A) receptor, the effects of substitution of this proline by unnatural amino acids led to the suggestion that trans-cis isomerization of the protein backbone at this position is integral to agonist-induced channel opening [Nature (2005) vol. 438, pp. 248-252]. We explored the generality of this conclusion using natural amino acid mutagenesis of the homologous human 5-HT(3)A receptor. The conserved proline (P303) was substituted by either a histidine or tryprophan and the mutant receptors were expressed in Xenopus oocytes. These mutations did not significantly affect the magnitude of agonist-mediated currents, compromise channel gating by 5-HT or inhibition of 5-HT-induced currents by either picrotoxin or d-tubocurarine. The mutations did, however, result in altered dependence on extracellular Ca(2+) concentration and a 10-fold increase in the rate of receptor desensitization. These results demonstrate an important role for P303 in 5-HT(3)A receptor function but indicate that trans-cis isomerization at this proline is unlikely to be a general mechanism underlying the gating process.
Collapse
Affiliation(s)
- Isabelle M Paulsen
- Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | | | | |
Collapse
|
31
|
Morelli E, Gemma S, Budriesi R, Campiani G, Novellino E, Fattorusso C, Catalanotti B, Coccone SS, Ros S, Borrelli G, Persico M, Fiorini I, Nacci V, Ioan P, Chiarini A, Hamon M, Cagnotto A, Mennini T, Fracasso C, Colovic M, Caccia S, Butini S. Specific Targeting of Peripheral Serotonin 5-HT3 Receptors. Synthesis, Biological Investigation, and Structure−Activity Relationships. J Med Chem 2009; 52:3548-62. [DOI: 10.1021/jm900018b] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Affiliation(s)
- Elena Morelli
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Sandra Gemma
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Roberta Budriesi
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Giuseppe Campiani
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Ettore Novellino
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Caterina Fattorusso
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Bruno Catalanotti
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Salvatore Sanna Coccone
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Sindu Ros
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Giuseppe Borrelli
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Marco Persico
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Isabella Fiorini
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Vito Nacci
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Pierfranco Ioan
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Alberto Chiarini
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Michel Hamon
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Alfredo Cagnotto
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Tiziana Mennini
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Claudia Fracasso
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Milena Colovic
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Silvio Caccia
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| | - Stefania Butini
- European Research Centre for Drug Discovery and Development, Banchi di Sotto 55, 53100 Siena, Italy, Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro 53100 Siena, Italy, Dipartimento di Chimica delle Sostanze Naturali (DCSN) e Dipartimento di Chimica Farmaceutica e Tossicologica (DCFT), Università di Napoli “Federico II”, Via D. Montesano 49, 80131 Napoli, Italy, Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Neurobiologie
| |
Collapse
|
32
|
Barnes NM, Hales TG, Lummis SC, Peters JA. The 5-HT3 receptor--the relationship between structure and function. Neuropharmacology 2009; 56:273-84. [PMID: 18761359 PMCID: PMC6485434 DOI: 10.1016/j.neuropharm.2008.08.003] [Citation(s) in RCA: 174] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2008] [Revised: 07/31/2008] [Accepted: 08/01/2008] [Indexed: 12/15/2022]
Abstract
The 5-hydroxytryptamine type-3 (5-HT3) receptor is a cation-selective ion channel of the Cys-loop superfamily. 5-HT3 receptor activation in the central and peripheral nervous systems evokes neuronal excitation and neurotransmitter release. Here, we review the relationship between the structure and the function of the 5-HT3 receptor. 5-HT3A and 5-HT3B subunits are well established components of 5-HT3 receptors but additional HTR3C, HTR3D and HTR3E genes expand the potential for molecular diversity within the family. Studies upon the relationship between subunit structure and the ionic selectivity and single channel conductances of 5-HT3 receptors have identified a novel domain (the intracellular MA-stretch) that contributes to ion permeation and selectivity. Conventional and unnatural amino acid mutagenesis of the extracellular domain of the receptor has revealed residues, within the principle (A-C) and complementary (D-F) loops, which are crucial to ligand binding. An area requiring much further investigation is the subunit composition of 5-HT3 receptors that are endogenous to neurones, and their regional expression within the central nervous system. We conclude by describing recent studies that have identified numerous HTR3A and HTR3B gene polymorphisms that impact upon 5-HT3 receptor function, or expression, and consider their relevance to (patho)physiology.
Collapse
Affiliation(s)
- Nicholas M. Barnes
- Cellular and Molecular Neuropharmacology Research Group, Department of Pharmacology, Division of Neuroscience, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
| | - Tim G. Hales
- Department of Pharmacology and Physiology, The George Washington University, Washington, DC 20037, USA
| | - Sarah C.R. Lummis
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
| | - John A. Peters
- Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, The University of Dundee, Dundee DD1 9SY, UK
| |
Collapse
|
33
|
A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residue. J Neurosci 2008; 28:10937-42. [PMID: 18945901 DOI: 10.1523/jneurosci.2540-08.2008] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Cys-loop receptor binding sites characteristically contain many aromatic amino acids. In nicotinic ACh and 5-HT3 receptors, a Trp residue forms a cation-pi interaction with the agonist, whereas in GABA(A) receptors, a Tyr performs this role. The glycine receptor binding site, however, contains predominantly Phe residues. Homology models suggest that two of these Phe side chains, Phe159 and Phe207, and possibly a third, Phe63, are positioned such that they could contribute to a cation-pi interaction with the primary amine of glycine. Here, we test this hypothesis by incorporation of a series of fluorinated Phe derivatives using unnatural amino acid mutagenesis. The data reveal a clear correlation between the glycine EC(50) value and the cation-pi binding ability of the fluorinated Phe derivatives at position 159, but not at positions 207 or 63, indicating a single cation-pi interaction between glycine and Phe159. The data thus provide an anchor point for locating glycine in its binding site, and demonstrate for the first time a cation-pi interaction between Phe and a neurotransmitter.
Collapse
|
34
|
Abstract
The 5-HT3 receptor belongs to a family of therapeutically important neurotransmitter-gated receptors whose ligand binding sites are formed by the convergence of six peptide loops (A-F). Here we have mutated 15 amino acid residues in and around loop B of the 5-HT3 receptor (Ser-177 to Asn-191) to Ala or a residue with similar chemical properties. Changes in [3H]granisetron binding affinity (Kd) and 5-HT EC50 were determined using receptors expressed in human embryonic kidney 293 cells. Substitutions at all but one residue (Thr-181) altered or eliminated binding for one or both mutants. Receptors were nonfunctional or EC50 values were altered for all but two mutants (S182T, I190L). Homology modeling indicates that loop B contributes two residues to a hydrophobic core that faces into the β-sandwich of the subunit, and the experimental data indicate that they are important for both the structure and the function of the receptor. The models also show that close to the apex of the loop (Ser-182 to Ile-190), loop B residues form an extensive network of hydrogen bonds, both with other loop B residues and with adjacent regions of the protein. Overall, the data suggest that loop B has a major role in maintaining the structure of the region by a series of noncovalent interactions that are easily disrupted by amino acid substitutions.
Collapse
|
35
|
Ci S, Ren T, Su Z. Investigating the putative binding-mode of GABA and diazepam within GABA A receptor using molecular modeling. Protein J 2008; 27:71-8. [PMID: 17805947 DOI: 10.1007/s10930-007-9109-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The three-dimensional structure of the GABA A receptor that included the ligand/agonist binding site was constructed and validated by using molecular modeling technology. Moreover, the putative binding-mode of GABA and diazepam with GABAA receptor were investigated by means of docking studies. Based on an rmsd-tolerance of 1.0 angstroms, the docking of GABA to alpha1/beta2 interface resulted in three multi-member conformational clusters and model 2 was supported by homologous sequence alignment data and experimental evidence. On the other hand, the docking of diazepam to alpha1/gamma2 interface revealed five multi-member conformational clusters in the binding site and model 1 seemed to represent the correct orientation of diazepam in the binding site.
Collapse
Affiliation(s)
- Suqin Ci
- National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100080, P.R. China
| | | | | |
Collapse
|
36
|
Price KL, Bower KS, Thompson AJ, Lester HA, Dougherty DA, Lummis SCR. A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptor. Biochemistry 2008; 47:6370-7. [PMID: 18498149 PMCID: PMC2649372 DOI: 10.1021/bi800222n] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The binding sites of Cys-loop receptors are formed from at least six loops (A-F). Here we have used mutagenesis, radioligand binding, voltage clamp electrophysiology, and homology modeling to probe the role of two residues in loop A of the 5-HT3 receptor: Asn128 and Glu129. The data show that substitution of Asn128, with a range of alternative natural and unnatural amino acids, changed the EC50 (from approximately 10-fold more potent to approximately 10-fold less potent than that of the wild type), increased the maximal peak current for mCPBG compared to 5-HT (R max) 2-19-fold, and decreased n H, indicating this residue is involved in receptor gating; we propose Asn128 faces away from the binding pocket and plays a role in facilitating transitions between conformational states. Substitutions of Glu129 resulted in functional receptors only when the residue could accept a hydrogen bond, but with both these and other substitutions, no [(3)H]granisetron binding could be detected, indicating a role in ligand binding. We propose that Glu129 faces into the binding pocket, where, through its ability to hydrogen bond, it plays a critical role in ligand binding. Thus, the data support a modified model of the 5-HT3 receptor binding site and show that loop A plays a critical role in both the ligand binding and function of this receptor.
Collapse
Affiliation(s)
- Kerry L Price
- Department of Biochemistry, University of Cambridge, UK
| | | | | | | | | | | |
Collapse
|
37
|
Wells GB. Structural answers and persistent questions about how nicotinic receptors work. FRONTIERS IN BIOSCIENCE : A JOURNAL AND VIRTUAL LIBRARY 2008; 13:5479-510. [PMID: 18508600 PMCID: PMC2430769 DOI: 10.2741/3094] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The electron diffraction structure of nicotinic acetylcholine receptor (nAChR) from Torpedo marmorata and the X-ray crystallographic structure of acetylcholine binding protein (AChBP) are providing new answers to persistent questions about how nAChRs function as biophysical machines and as participants in cellular and systems physiology. New high-resolution information about nAChR structures might come from advances in crystallography and NMR, from extracellular domain nAChRs as high fidelity models, and from prokaryotic nicotinoid proteins. At the level of biophysics, structures of different nAChRs with different pharmacological profiles and kinetics will help describe how agonists and antagonists bind to orthosteric binding sites, how allosteric modulators affect function by binding outside these sites, how nAChRs control ion flow, and how large cytoplasmic domains affect function. At the level of cellular and systems physiology, structures of nAChRs will help characterize interactions with other cellular components, including lipids and trafficking and signaling proteins, and contribute to understanding the roles of nAChRs in addiction, neurodegeneration, and mental illness. Understanding nAChRs at an atomic level will be important for designing interventions for these pathologies.
Collapse
Affiliation(s)
- Gregg B Wells
- Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843-1114, USA.
| |
Collapse
|
38
|
Bower KS, Price KL, Sturdee LE, Dayrell M, Dougherty DA, Lummis SC. 5-Fluorotryptamine is a partial agonist at 5-HT3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function. Eur J Pharmacol 2008; 580:291-7. [PMID: 18082160 PMCID: PMC2649378 DOI: 10.1016/j.ejphar.2007.11.014] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2007] [Accepted: 11/09/2007] [Indexed: 11/19/2022]
Abstract
Antagonists, but not agonists, of the 5-HT3 receptor are useful therapeutic agents, and it is possible that partial agonists may also be potentially useful in the clinic. Here we show that 5-fluorotryptamine (5-FT) is a partial agonist at both 5-HT3A and 5-HT3AB receptors with an Rmax (Imax/Imax 5-HT) of 0.64 and 0.45 respectively. It is about 10 fold less potent than 5-HT: EC50=16 and 27 microM, and Ki for displacement of [3H]granisetron binding=0.8 and 1.8 microM for 5-HT3A and 5-HT3AB receptors respectively. We have also explored the potencies and efficacies of tryptamine and a range of 5-substituted tryptamine derivatives. At 5-HT3A receptors tryptamine is a weak (Rmax=0.15), low affinity (EC50=113 microM; Ki=4.8 microM) partial agonist, while 5-chlorotryptamine has a similar affinity to 5-FT (EC50=8.1 microM; Ki=2.7 microM) but is a very weak partial agonist (Rmax=0. 0037). These, and data from 5-methyltryptamine and 5-methoxytryptamine, reveal the importance of size and electronegativity at this location for efficient channel opening.
Collapse
Affiliation(s)
- Kiowa S. Bower
- California Institute of Technology, Pasadena, California, USA
| | - Kerry L. Price
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| | | | - Mariza Dayrell
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| | | | | |
Collapse
|
39
|
Padgett CL, Lummis SCR. The F-loop of the GABA A receptor gamma2 subunit contributes to benzodiazepine modulation. J Biol Chem 2007; 283:2702-8. [PMID: 17974564 DOI: 10.1074/jbc.m705699200] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
GABA(A) receptors can be modulated by benzodiazepines, although these compounds do not directly activate or inhibit the receptors. The prototypic benzodiazepine, diazepam, potentiates responses to GABA in GABA(A) receptors that contain a gamma subunit. Here we have used mutagenesis, radioligand binding, voltage clamp electrophysiology, and homology modeling to probe the role of the F-loop residues Asp(192)-Arg(197) in the GABA(A) receptor gamma(2) subunit in diazepam potentiation of the GABA response. Substitution of all of these residues with Ala and/or a residue with similar chemical properties to the wild type residue decreased the level of diazepam potentiation, and one mutation (D192A) resulted in its complete ablation. None of the mutations changed the GABA EC(50) or the [(3)H]flumazenil binding affinity, suggesting they do not affect GABA or benzodiazepine binding characteristics; we therefore propose that they are involved in the diazepam-mediated conformational change that results in an increased response to GABA. Homology models of the receptor binding pocket in agonist-bound and unbound states suggest that the F-loop is flexible and has different orientations in the two states. Considering our data in relation to these models, we find that the F-loop residues could contribute to hydrogen bond networks and hydrophobic interactions with neighboring residues that change during receptor activation.
Collapse
Affiliation(s)
- Claire L Padgett
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom
| | | |
Collapse
|
40
|
Ci SQ, Ren TR, Ma CX, Su ZG. Modeling of αk/γ2 (k=1, 2, 3 and 5) interface of GABAA receptor and docking studies with zolpidem: Implications for selectivity. J Mol Graph Model 2007; 26:537-45. [PMID: 17451983 DOI: 10.1016/j.jmgm.2007.03.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2006] [Revised: 03/18/2007] [Accepted: 03/18/2007] [Indexed: 11/28/2022]
Abstract
The three-dimensional models of the alphak/gamma2 (k=1, 2, 3 and 5) interface of GABA(A) receptors, which included the agonist-binding site, were constructed and validated by molecular modeling technology. To investigate the mechanism of alpha subunit selectivity of zolpidem, docking calculations were used to illustrate the potential binding modes of zolpidem with different alpha subtypes. The results revealed that there were three reasons resulting in the distinct binding affinity of zolpidem to different alpha subtype. Firstly, the number of hydrogen bonds of agonist-receptor complex would determine the magnitude of binding affinity. Secondly, the His residue in loop A of alpha subunit was indicated as a key role of benzodiazepine binding. Thirdly, the side chain of Glu in loop C reduced the affinity of zolpidem to those receptors containing alpha2, alpha3 or alpha5 subunits.
Collapse
Affiliation(s)
- Su-Qin Ci
- National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100080, China
| | | | | | | |
Collapse
|
41
|
Abstract
MD-354 (meta-chlorophenylguanidine) has been identified as a member of a novel class of 5-HT(3) serotonin receptor agonists. MD-354 is a 5-HT(3) receptor partial agonist that has been shown to behave as an agonist in some assays, and as an antagonist in others. MD-354 also binds at alpha-adrenoceptors (ARs) and displays an affinity for alpha(2B)-ARs comparable to its affinity for 5-HT(3) receptors. Although devoid of antinociceptive actions following systemic administration alone, MD-354 markedly enhances the antinociceptive actions of clonidine in the mouse tail-flick assay without potentiating the sedative side effects of clonidine. Although studies with MD-354 are still in progress, some pharmacological findings are described here. MD-354-related agents may represent drug adjuvants for the relief of severe pain.
Collapse
Affiliation(s)
- Malgorzata Dukat
- Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298-0540, USA.
| | | | | |
Collapse
|
42
|
Thompson AJ, Lochner M, Lummis SCR. The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors. Br J Pharmacol 2007; 151:666-77. [PMID: 17502851 PMCID: PMC1994240 DOI: 10.1038/sj.bjp.0707238] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND AND PURPOSE The antimalarial compounds quinine, chloroquine and mefloquine affect the electrophysiological properties of Cys-loop receptors and have structural similarities to 5-HT(3) receptor antagonists. They may therefore act at 5-HT(3) receptors. EXPERIMENTAL APPROACH The effects of quinine, chloroquine and mefloquine on electrophysiological and ligand binding properties of 5-HT(3A) receptors expressed in HEK 293 cells and Xenopus oocytes were examined. The compounds were also docked into models of the binding site. KEY RESULTS 5-HT(3) responses were blocked with IC (50) values of 13.4 microM, 11.8 microM and 9.36 microM for quinine, chloroquine and mefloquine. Schild plots indicated quinine and chloroquine behaved competitively with pA (2) values of 4.92 (K (B)=12.0 microM) and 4.97 (K (B)=16.4 microM). Mefloquine displayed weakly voltage-dependent, non-competitive inhibition consistent with channel block. On and off rates for quinine and chloroquine indicated a simple bimolecular reaction scheme. Quinine, chloroquine and mefloquine displaced [(3)H]granisetron with K (i) values of 15.0, 24.2 and 35.7 microM. Docking of quinine into a homology model of the 5-HT(3) receptor binding site located the tertiary ammonium between W183 and Y234, and the quinoline ring towards the membrane, stabilised by a hydrogen bond with E129. For chloroquine, the quinoline ring was positioned between W183 and Y234 and the tertiary ammonium stabilised by interactions with F226. CONCLUSIONS AND IMPLICATIONS This study shows that quinine and chloroquine competitively inhibit 5-HT(3) receptors, while mefloquine inhibits predominantly non-competitively. Both quinine and chloroquine can be docked into a receptor binding site model, consistent with their structural homology to 5-HT(3) receptor antagonists.
Collapse
Affiliation(s)
- A J Thompson
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| | | | | |
Collapse
|
43
|
Abstract
The 5-HT3 receptor is a neurotransmitter-gated ion channel. It is a member of the Cys-loop family of receptors, which also includes nicotinic acetylcholine, glycine and GABAA receptors. Each member of the family consists of an arrangement of five subunits surrounding a central ion-conducting pore. The 5-HT3 receptor binding site is composed of six loops from two adjacent subunits, and the critical ligand binding residues within these loops are well documented. There are a range of 5-HT3 receptor agonists and competitive antagonists, but it is the antagonists that dominate their clinical use. Studies have proposed a range of disease symptoms that might be amenable to 5-HT3 receptor selective compounds; however, so far only the treatment of emesis and irritable bowel syndrome have been fully realised. In this review, the authors look at the structure, function and distribution of 5-HT3 receptors and how this may influence their role in disease. The authors also describe the existing clinical applications of 5-HT3 antagonists and the future potential of these drugs.
Collapse
Affiliation(s)
- Andrew J Thompson
- University of Cambridge, Department of Biochemistry, Tennis Court Road, Cambridge , CB2 1QW, UK
| | - Sarah CR Lummis
- University of Cambridge, Department of Biochemistry, Tennis Court Road, Cambridge , CB2 1QW, UK
| |
Collapse
|
44
|
Zhang R, Wen X, Militante J, Hester B, Rhubottom HE, Sun H, Leidenheimer NJ, Yan D, White MM, Machu TK. The role of loop F residues in determining differential d-tubocurarine potencies in mouse and human 5-hydroxytryptamine 3A receptors. Biochemistry 2007; 46:1194-204. [PMID: 17260949 DOI: 10.1021/bi0616100] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The competitive antagonist d-tubocurarine (curare) has greater potency at mouse than at human 5-hydroxytryptamine 3A (5-HT3A) receptors, despite 84% amino acid sequence identity between the receptors. Within the ligand binding domain of this receptor are six loops (A-F). A previous report demonstrated that loop C of the 5-HT3A receptor contributed to differential potency between the receptors [Hope, A. G. et al. (1999) Mol. Pharmacol. 55, 1037-1043]. The present study tested the hypothesis that loop F plays a significant role in conferring interspecies curare potency differences. Wild-type, chimeric, and point mutant 5-HT3A receptors were expressed in Xenopus oocytes, and two-electrode voltage clamp electrophysiological recordings were performed. Our data suggest that loops C and F contribute to curare potency, given that the curare IC50's (concentration of drug that produces 50% inhibition of the response) for chimeric human receptors with substitutions of mouse residues in loop C (40.07 +/- 2.52 nM) or loop F (131.8 +/- 5.95 nM) were intermediate between those for the mouse (12.99 +/- 0.77 nM) and human (1817 +/- 92.36 nM) wild-type receptors. Two human point mutant receptors containing mouse receptor substitutions in loop F (H-K195E or H-V202I) had significantly lower curare IC50's than that of the human receptor. The human double mutant receptor, H-K195E,V202I, had the same curare IC50 (133.8 +/- 6.38 nM) as that of the human receptor containing all six loop F mouse substitutions. These results demonstrate that two loop F residues make a significant contribution in determining curare potency at the 5-HT3A receptor.
Collapse
Affiliation(s)
- Ran Zhang
- Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, 3601 Fourth Street, Lubbock, Texas 79430, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Melis C, Chau PL, Price KL, Lummis SCR, Molteni C. Exploring the binding of serotonin to the 5-HT3 receptor by density functional theory. J Phys Chem B 2007; 110:26313-9. [PMID: 17181290 PMCID: PMC2649374 DOI: 10.1021/jp063762a] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The 5-HT3 receptor is a typical ligand-gated ion channel of the Cys-loop superfamily, which is activated by binding of serotonin (5-HT). Models of the binding site of this protein reveal potential interactions between 5-HT and Tyr143, Tyr153, and Tyr234. Here we describe a series of ab initio calculations, based on density functional theory, to assess the effects of mutating these tyrosine residues on the binding of 5-HT. A series of mutations to these tyrosines, previously studied experimentally, were tested, and the binding energies compared with the available experimental data. Our results show that Tyr153 could form a hydrogen bond with the tertiary amine of 5-HT, and that mutation in this location revealed binding energies broadly in line with experimentally determined EC50s. Tyr143 could also form a hydrogen bond, but as EC50s do not relate to binding energies, it is unlikely that such a bond is formed here. Tyr234 is quite distinct in that it may interact with 5-HT via a mixed hydrogen bond/cation-pi interaction.
Collapse
Affiliation(s)
- Claudio Melis
- Physics Department, King’s College London, Strand, London WC2R 2LS, United Kingdom, Bioinformatique Structurale, CNRS URA 2185
| | | | - Kerry L. Price
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, United Kingdom
| | - Sarah C. R. Lummis
- Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, United Kingdom
| | - Carla Molteni
- Physics Department, King’s College London, Strand, London WC2R 2LS, United Kingdom, Bioinformatique Structurale, CNRS URA 2185
- Address correspondence to this author. E-mail:
| |
Collapse
|
46
|
Peters JA, Carland JE, Cooper MA, Livesey MR, Deeb TZ, Hales TG, Lambert JJ. Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors. Biochem Soc Trans 2007; 34:882-6. [PMID: 17052220 DOI: 10.1042/bst0340882] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Nicotinic ACh (acetylcholine) and 5-HT3 (5-hydroxytryptamine type-3) receptors are cation-selective ion channels of the Cys-loop transmitter-gated ion channel superfamily. Numerous lines of evidence indicate that the channel lining domain of such receptors is formed by the alpha-helical M2 domain (second transmembrane domain) contributed by each of five subunits present within the receptor complex. Specific amino acid residues within the M2 domain have accordingly been demonstrated to influence both single-channel conductance (gamma) and ion selectivity. However, it is now clear from work performed on the homomeric 5-HT3A receptor, heteromeric 5-HT3A/5-HT3B receptor and 5-HT3A/5-HT3B receptor subunit chimaeric constructs that an additional major determinant of gamma resides within a cytoplasmic domain of the receptor termed the MA-stretch (membrane-associated stretch). The MA-stretch, within the M3-M4 loop, is not traditionally thought to be implicated in ion permeation and selection. Here, we describe how such observations extend to a representative neuronal nicotinic ACh receptor composed of alpha4 and beta2 subunits and, by inference, probably other members of the Cys-loop family. In addition, we will attempt to interpret our results within the context of a recently developed atomic scale model of the nicotinic ACh receptor of Torpedo marmorata (marbled electric ray).
Collapse
Affiliation(s)
- J A Peters
- Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, The University of Dundee, Dundee DD1 9SY, UK.
| | | | | | | | | | | | | |
Collapse
|
47
|
Sullivan NL, Thompson AJ, Price KL, Lummis SCR. Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3 receptor. Mol Membr Biol 2007; 23:442-51. [PMID: 17060161 PMCID: PMC2649376 DOI: 10.1080/09687860600831539] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
The ligand binding pocket of Cys-loop receptors consists of a number of binding loops termed A-F. Here we examine the 5-HT3 receptor loop A residues Asn-128, Glu-129 and Phe-130 using modelling, mutagenesis, radioligand binding and functional studies on HEK 293 cells. Replacement of Asn-128 results in receptors that have wild type [3H]granisetron binding characteristics but large changes (ranging from a five-fold decrease to a 1500-fold increase) in the 5-HT EC50 when compared to wild type receptors. Phe-130 mutant receptors show both increases and decreases in Kd and EC50 values, depending on the amino acid substituted. The most critical of these residues appears to be Glu-129; its replacement with a range of other amino acids results in non-binding and non-functional receptors. Lack of binding and function in some, but not all, of these receptors is due to poor membrane expression. These data suggest that Glu-129 is important primarily for receptor expression, although it may also play a role in ligand binding; Phe-130 is important for both ligand binding and receptor function, and Asn-128 plays a larger role in receptor function than ligand binding. In light of these results, we have created two new homology models of the 5-HT3 receptor, with alternative positions of loop A. In our preferred model Glu-129 and Phe-130 contribute to the binding site, while the location of Asn-128 immediately behind the binding pocket could contribute to the conformation changes that result in receptor gating. This study provides a new model of the 5-HT3 receptor binding pocket, and also highlights the importance of experimental data to support modelling studies.
Collapse
Affiliation(s)
- Nora L Sullivan
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| | | | | | | |
Collapse
|
48
|
Martinelli A, Tuccinardi T. An overview of recent developments in GPCR modelling: methods and validation. Expert Opin Drug Discov 2006; 1:459-76. [DOI: 10.1517/17460441.1.5.459] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
49
|
Chau PL. Simulations of biomolecule unbinding from protein using DL_POLY. MOLECULAR SIMULATION 2006. [DOI: 10.1080/08927020600835640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Harrison NJ, Lummis SCR. Locating the carboxylate group of GABA in the homomeric rho GABA(A) receptor ligand-binding pocket. J Biol Chem 2006; 281:24455-61. [PMID: 16754677 DOI: 10.1074/jbc.m601775200] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
gamma-Aminobutyric acid, type A (GABA(A)) receptors, of which the GABA(C) receptor family is a subgroup, are members of the Cys loop family of neurotransmitter receptors. Homology modeling of the extracellular domain of these proteins has revealed many molecular details, but it is not yet clear how GABA is orientated in the binding pocket. Here we have examined the role of arginine residues that the homology model locates in or close to the binding site of the GABA(C) receptor (Arg-104, Arg-170, Arg-158, and Arg-249) using mutagenesis and functional studies. The data suggest that Arg-158 is critical for GABA binding and/or function; substitution with Lys, Ala, or Glu resulted in nonfunctional receptors, and modeling placed the carboxylate of GABA within 3A of this residue. Substitution of Arg-104 with Ala or Glu resulted in >10,000-fold increases in EC(50) values compared with wild type receptors, and modeling indicated a role of this residue both in binding GABA and in the structure of the binding pocket. Substitution of Arg-170 with Asp or Ala yielded nonfunctional receptors, whereas Lys caused an approximately 10-fold increase in EC(50). Arg-249 was substituted with Ala, Glu, or Asp with relatively small ( approximately 4-30-fold) changes in EC(50). These and data from other residues that the model suggested could interact with GABA (His-105, Ser-168, and Ser-243) support a location for GABA in the binding site with its carboxylate pincered between Arg-158 and Arg-104, with Arg-104, Arg-170, and Arg-249 contributing to the structure of the binding pocket through salt bridges and/or hydrogen bonds.
Collapse
Affiliation(s)
- Neil J Harrison
- Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom
| | | |
Collapse
|